KUALA LUMPUR, July 17 (Bernama) -- The Society for Medical Decision Making (SMDM) has presented its highest career honour, the 2026 Career Achievement Award, to Professor Uwe Siebert of UMIT TIROL and Harvard University.
Presented during the Leadership Awards Session at the SMDM 48th Annual Meeting in Oslo, Norway, Professor Siebert was recognised for his decades of transformative contributions to medical decision-making through groundbreaking research, international leadership, education and service.
The award recognises distinguished senior investigators whose sustained contributions have significantly advanced the science and practice of medical decision-making. Recipients are selected via a competitive nomination process following an open call and are evaluated by the Society's Awards Committee.
“This award reflects not only my own work but also the dedication and expertise of my entire team. It also reflects the support, encouragement, and inspiration I have received throughout my career from my students, fellows, colleagues, mentors, friends, and my family,” said Professor Siebert in a statement.
Professor Siebert serves as Professor of Public Health, Medical Decision Making and Health Technology Assessment and Head of the Institute of Public Health, Medical Decision Making and Health Technology Assessment at UMIT TIROL – University for Health Sciences and Health Technology in Austria.
He is also Adjunct Professor of Health Policy and Management, and Epidemiology, at the Harvard T.H. Chan School of Public Health and an affiliated researcher at the Center for Health Technology Assessment at Mass General Brigham, Harvard Medical School.
Professor Siebert earned his Master of Public Health from the Munich School of Public Health and Epidemiology and both his Master of Science in Epidemiology and Doctor of Science in Health Policy and Management from the Harvard School of Public Health.
His pioneering work in medical decision analysis, benefit-harm assessment and health-economic evaluation has advanced the science of evidence-based healthcare while directly informing clinical guidelines, cancer screening programmes, health technology assessments, reimbursement decisions and national health policies worldwide.
Throughout his career, Professor Siebert has advised governments, health technology assessment agencies, professional societies and international organisations on evidence-based policy and healthcare decision-making, and has authored more than 500 publications.
-- BERNAMA
No comments:
Post a Comment